BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33226456)

  • 1. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
    Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
    Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous antegrade ureteral stent placement: single center experience.
    Kahriman G; Özcan N; Doğan A; İmamoğlu H; Demirtaş A
    Diagn Interv Radiol; 2019 Mar; 25(2):127-133. PubMed ID: 30860076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
    Song Y; Fei X; Song Y
    Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between Antegrade versus Retrograde Ureteral Stent Placement for Malignant Ureteral Obstruction.
    Kim HJ; Yoon CJ; Lee S; Lee JH; Choi WS; Lee CH
    J Vasc Interv Radiol; 2022 Oct; 33(10):1199-1206. PubMed ID: 35809804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antegrade Ureteral Stenting is a Good Alternative for the Retrograde Approach.
    van der Meer RW; Weltings S; van Erkel AR; Roshani H; Elzevier HW; van Dijk LC; van Overhagen H
    Curr Urol; 2017 Jul; 10(2):87-91. PubMed ID: 28785193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.
    Kim SH; Park B; Joo J; Joung JY; Seo HK; Chung J; Lee KH
    PLoS One; 2017; 12(9):e0184965. PubMed ID: 28931043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroscopy-guided percutaneous antegrade approach for ureteral stent placement in children: a single-center experience.
    Herdem N; Kahriman G; Dogan A; Hosgecin C; Turan C; Oz Gergin O
    Acta Radiol; 2022 Sep; 63(9):1270-1275. PubMed ID: 34259018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.
    Hausegger KA; Portugaller HR
    Eur Radiol; 2006 Sep; 16(9):2016-30. PubMed ID: 16547709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of fluoroscopic guided percutaneous antegrade ureteral stents placement for the treatment of malignant ureteral obstruction.
    Liu Y; Wu K; Lai H; Zeng Z; Zhang B
    J Xray Sci Technol; 2019; 27(3):453-460. PubMed ID: 30909269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of single double-J stent failure in malignant ureteral obstruction: tandem ureteral stenting with less frequent stent exchange.
    Akıncı D; Ünal E; Çiftçi TT; Özkan OŞ; Akhan O
    Diagn Interv Radiol; 2023 Mar; 29(2):312-317. PubMed ID: 36987982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous antegrade removal of double J ureteral stents via a 9-F nephrostomy route.
    Shin JH; Yoon HK; Ko GY; Sung KB; Song HY; Choi E; Kim JH; Kim JW; Kim KR; Kwon J
    J Vasc Interv Radiol; 2007 Sep; 18(9):1156-61. PubMed ID: 17804779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of Double-Layered Polytetrafluoroethylene Membrane-Covered Self-Expandable Segmental Metallic Stents (Uventa) in Patients with Chronic Ureteral Obstructions: Is It Really Safe?
    Kim M; Hong B; Park HK
    J Endourol; 2016 Dec; 30(12):1339-1346. PubMed ID: 27736158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placement of double-J stent in patients with malignant ureteral obstruction: antegrade or retrograde approach?
    Turgut B; Bayraktar AM; Bakdık S; Hamarat MB; Öncü F; Gönen M; Tolu I
    Clin Radiol; 2019 Dec; 74(12):976.e11-976.e17. PubMed ID: 31506172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases.
    Lu DS; Papanicolaou N; Girard M; Lee MJ; Yoder IC
    Clin Radiol; 1994 Apr; 49(4):256-61. PubMed ID: 8162683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of percutaneous nephrostomy, percutaneous insertion of ureteral endoprosthesis, and replacement procedures.
    Kaskarelis IS; Papadaki MG; Malliaraki NE; Robotis ED; Malagari KS; Piperopoulos PN
    Cardiovasc Intervent Radiol; 2001; 24(4):224-8. PubMed ID: 11779010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Matsuura H; Arase S; Hori Y
    Int J Clin Oncol; 2019 Mar; 24(3):306-312. PubMed ID: 30298199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
    Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
    J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
    [No Abstract]   [Full Text] [Related]  

  • 20. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients.
    Patel U; Abubacker MZ
    Radiology; 2004 Feb; 230(2):435-42. PubMed ID: 14688404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.